Insider · CIK 0001256126

Mueller Peter

CIK 0001256126 Name as filed on the most recent filing

Filed as Mueller Peter (71)

130 transaction lines · from 71 filings · filed 2005-12-21 to 2019-08-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

130 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2012-08-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 351,846, disposed Open Form 4 filing 0001209191-12-042410
2012-07-16 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 343,060, disposed Open Form 4 filing 0001209191-12-038459
2012-06-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 366,405, disposed Open Form 4 filing 0001209191-12-034518
2012-05-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3 lines 417,824, disposed Open Form 4 filing 0001209191-12-028597
2012-05-07 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 4,216,085, disposed Open Form 4 filing 0001209191-12-027017
2011-09-20 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 1,312,500, disposed Open Form 4 filing 0001209191-11-048625
2011-09-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 476,848, disposed Open Form 4 filing 0001209191-11-048122
2011-08-29 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 427,595, disposed Open Form 4 filing 0001209191-11-045977
2011-07-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 126,700, disposed Open Form 4 filing 0001209191-11-039764
2011-06-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 116,698, disposed Open Form 4 filing 0001209191-11-034941
2011-05-16 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3 lines 142,554, disposed Open Form 4 filing 0001209191-11-029274
2011-04-25 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 625,000, disposed Open Form 4 filing 0001209191-11-024396
2011-04-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 118,716, disposed Open Form 4 filing 0001209191-11-023372
2011-04-11 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 1,921,020, disposed Open Form 4 filing 0001209191-11-022756
2010-11-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 55,088, disposed Open Form 4 filing 0000875320-10-000058
2010-10-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 57,035, disposed Open Form 4 filing 0000875320-10-000053
2010-09-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 59,552, disposed Open Form 4 filing 0000875320-10-000050
2010-08-16 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 58,208, disposed Open Form 4 filing 0000875320-10-000049
2010-07-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 54,784, disposed Open Form 4 filing 0000875320-10-000047
2010-06-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 55,888, disposed Open Form 4 filing 0000875320-10-000034
2010-05-17 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 59,824, disposed Open Form 4 filing 0000875320-10-000023
2010-05-07 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 225,571, disposed Open Form 4 filing 0000875320-10-000022
2010-04-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 63,376, disposed Open Form 4 filing 0000875320-10-000018
2010-03-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 68,928, disposed Open Form 4 filing 0000875320-10-000016
2010-02-16 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 61,680, disposed Open Form 4 filing 0000875320-10-000014
2010-02-03 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 154,029, disposed Open Form 4 filing 0000875320-10-000004
2010-01-26 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 79,804, disposed Open Form 4 filing 0000875320-10-000002
2010-01-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 64,519, disposed Open Form 4 filing 0000875320-10-000001
2009-12-04 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 63,392, disposed Open Form 4 filing 0000875320-09-000101
2009-07-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 78,912, disposed Open Form 4 filing 0000875320-09-000060
2009-06-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 74,448, disposed Open Form 4 filing 0000875320-09-000046
2009-05-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 68,544, disposed Open Form 4 filing 0000875320-09-000032
2009-05-07 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 370,316, disposed Open Form 4 filing 0000875320-09-000024
2009-04-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 64,752, disposed Open Form 4 filing 0000875320-09-000019
2009-03-16 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 68,250, disposed Open Form 4 filing 0000875320-09-000017

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 12
  • Open-market sale 118
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. MUELLER PETER, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001256126

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.